STK4-AS1通过MYG1/Notch信号通路对食管鳞癌恶性生物学行为的影响

doi:10.3969/j.issn.1006-5725.2025.17.008

Abstract

Abstract:

Objective To investigate the role of STK4?AS1 in regulating the proliferation， invasion， and migration of esophageal squamous cell carcinoma （ESCC） cells through the MYG1/Notch signaling pathway. Methods Quantitative real?time PCR （qRT?PCR） was used to detect the expression of STK4?AS1 in ESCC cells. MTS assay， wound healing and Transwell assay were conducted to explore the proliferation， migration， and invasion abilities in each group in Eca109 and Kyse150 cells. mRNA sequencing （mRNA?seq） was used to detect the downstream target genes of STK4?AS1. KEGG functional enrichment analyses were used to predict the possible biological processes and signaling pathways. qRT?PCR and western blot were performed to identify mRNA expression of MYG1 and the key downstream transcription factors HES1， HES5， and HEY1 of the Notch signaling pathway， as well as the protein expression of NICD1. Co?transfection plasmids （for over?expressing STK4?AS1 and MYG1） were used to detect the mRNA expression of HES1， HES5， and HEY1 and the protein expression of NICD1 which acted as the key downstream transcription factors in the Notch signaling pathway， as well as the effects on the proliferation， migration， and invasion abilities of ESCC cells. Results The expression of STK4?AS1 was decreased in ESCC cell lines （P < 0.01）. Over?expression of STK4?AS1 inhibited the proliferation， migration and invasion abilities in Eca109 and Kyse150 cells （P < 0.05）. STK4?AS1 negatively regulated the expression of MYG1 （P < 0.01）， and the expression of MYG1 was increased in ESCC cell lines （P < 0.01）. Over?expression of MYG1 could partially reverse the effect of STK4?AS1 on the malignant biological behavior of Eca109 and Kyse150 cells （P < 0.05）， as well as the mRNA expressions of HES1， HES5， and HEY1 and the protein expression of NICD1 （P < 0.05）. Conclusion STK4?AS1 affects the malignant biological behaviors of ESCC through the MYG1/Notch signaling pathway。

Key words: esophageal squamous cell carcinoma, long non?coding RNA, STK4?AS1, Notch signaling pathway

CLC Number:

R735.1

Bo FENG,Jiarui CAO,Dongdong LI,Yanchao XU,Chunzheng MA. Role of STK4⁃AS1 in regulating malignant biological behavior of esophageal squamous cell carcinoma through the MYG1/Notch signaling pathway[J]. The Journal of Practical Medicine, 2025, 41(17): 2661-2669.

Figures/Tables 5

References 25

[1]	BRAY F， LAVERSANNE M， SUNG H， et al. Global cancer statistics 2022： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］. CA Cancer J Clin， 2024， 74（3）：229-263. doi:10.3322/caac.21834 doi: 10.3322/caac.21834
[2]	YANG H， WANG F， HALLEMEIER C L， et al. Oesophageal cancer ［J］. Lancet， 2024， 404（10466）：1991-2005. doi:10.1016/s0140-6736(24)02226-8 doi: 10.1016/s0140-6736(24)02226-8
[3]	谷变利，马丽霞，石林林，等. 食管癌流行病学研究现状及展望［J］.食管疾病， 2024， 6（2）：148-151.
[4]	杨雄涛，王鑫. 食管癌综合治疗新进展［J］. 中国肿瘤临床， 2023， 50（2）：98-103. doi:10.12354/j.issn.1000-8179.2023.20221079 doi: 10.12354/j.issn.1000-8179.2023.20221079
[5]	MARTON É， VARGA A， DOMOSZLAI D， et al. Non-coding RNAs in Cancer： Structure， Function， and Clinical Application ［J］. Cancers （Basel）， 2025， 17（4）：579. doi:10.3390/cancers17040579 doi: 10.3390/cancers17040579
[6]	CHEN F， LI Z， DENG C， et al. Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma ［J］. J Transl Med， 2019， 17（1）：299. doi:10.1186/s12967-019-2049-2 doi: 10.1186/s12967-019-2049-2
[7]	HUANG S， LYU S， GAO Z， et al. m6A-related lncRNAs are potential biomarkers for the prognosis of metastatic skin cutaneous melanoma ［J］. Front Mol Biosci， 2021， 8：687760. doi:10.3389/fmolb.2021.687760 doi: 10.3389/fmolb.2021.687760
[8]	CHODURSKA B， KUNEJ T. Long non-coding RNAs in humans： Classification， genomic organization and function ［J］. Noncoding RNA Res， 2025， 11：313-327. doi:10.1016/j.ncrna.2025.01.004 doi: 10.1016/j.ncrna.2025.01.004
[9]	CHEN L L， KIM V N. Small and long non-coding RNAs： Past， present， and future ［J］. Cell， 2024， 187（23）：6451-6485. doi:10.1016/j.cell.2024.10.024 doi: 10.1016/j.cell.2024.10.024
[10]	ZHANG L， WANG Y， GAO J， et al. Non‑coding RNA： A promising diagnostic biomarker and therapeutic target for esophageal squamous cell carcinoma （Review）［J］. Oncol Lett， 2024， 27（6）：255. doi:10.3892/ol.2024.14388 doi: 10.3892/ol.2024.14388
[11]	LENG X， ZHANG M， XU Y， et al. Non-coding RNAs as therapeutic targets in cancer and its clinical application ［J］. J Pharm Anal， 2024， 14（7）：100947. doi:10.1016/j.jpha.2024.02.001 doi: 10.1016/j.jpha.2024.02.001
[12]	何丽妃，朱琳，薛峰，等. LINC01772对A549细胞周期、凋亡及放疗敏感性的影响［J］. 实用医学杂志， 2025， 41（5）：657-663.
[13]	向威，吕磊，郑福鑫，等. LncRNA FOXP4-AS1调控EZH2/LATS2轴对膀胱尿路上皮癌细胞增殖与迁移的影响［J］. 实用医学杂志， 2024， 40（20）： 2819-2827.
[14]	YAO W， HOU J， LIU G， et al. LncRNA STK4 antisense RNA 1 （STK4-AS1） promoted osteosarcoma by inhibiting p53 expression ［J］. Cancer Biomark， 2023， 36（1）：1-16. doi:10.3233/cbm-210291 doi: 10.3233/cbm-210291
[15]	ZENG X， DU S， GENG L， et al. Nc-RNA-mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma ［J］. Cancer Med， 2024， 13（15）： e70105. doi:10.1002/cam4.70105 doi: 10.1002/cam4.70105
[16]	PHILIPS M A， VIKESA J， LUUK H， et al. Characterization of MYG1 gene and protein： subcellular distribution and function ［J］. Biol Cell， 2009， 101（6）：361-373. doi:10.1042/bc20080086 doi: 10.1042/bc20080086
[17]	HAN X， LI A， WANG W， et al. MYG1 promotes proliferation and inhibits autophagy in lung adenocarcinoma cells via the AMPK/mTOR complex 1 signaling pathway ［J］. Oncol Lett， 2021， 21（4）：334. doi:10.3892/ol.2021.12595 doi: 10.3892/ol.2021.12595
[18]	CHEN J， DUAN S， WANG Y， et al. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration ［J］. Nat Commun， 2024， 15（1）：4969. doi:10.1038/s41467-024-49221-0 doi: 10.1038/s41467-024-49221-0
[19]	LIU X， ZHU Y， HUANG W， et al. MYG1 interacts with HSP90 to promote breast cancer progression through Wnt/β-catenin and Notch signaling pathways ［J］. Exp Cell Res， 2025， 446（1）：114448. doi:10.1016/j.yexcr.2025.114448 doi: 10.1016/j.yexcr.2025.114448
[20]	SHI Q， XUE C， ZENG Y， et al. Notch signaling pathway in cancer： from mechanistic insights to targeted therapies ［J］. Signal Transduct Target Ther， 2024， 9（1）：128. doi:10.1038/s41392-024-01828-x doi: 10.1038/s41392-024-01828-x
[21]	BEDOLLA N， WU H， LIU L， et al. Gallic acid suppresses esophageal squamous cell carcinoma progression and enhances cisplatin chemosensitivity through IL-6/STAT3/Notch pathway ［J］. Oncol Res， 2025， 33（6）：1473-1484. doi:10.32604/or.2025.060151 doi: 10.32604/or.2025.060151
[22]	SAADH M J， OMAR T M， BALLAL S， et al. Notch signaling and cancer： Insights into chemoresistance， immune evasion， and immunotherapy ［J］. Gene， 2025， 955：149461. doi:10.1016/j.gene.2025.149461 doi: 10.1016/j.gene.2025.149461
[23]	HE Z， ZHONG Y， REGMI P， et al. Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway ［J］. Mol Cancer， 2024， 23（1）：65. doi:10.1186/s12943-024-01979-z doi: 10.1186/s12943-024-01979-z
[24]	ZHANG Z， LU Y X， LIU F， et al. lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1［J］. Proc Natl Acad Sci USA， 2023， 120（8）： e2206694120. doi:10.1073/pnas.2206694120 doi: 10.1073/pnas.2206694120
[25]	徐俐，胡珊珊，赵海明. LncRNA GNAS-AS1通过调节miR-449a/Notch1轴参与胃癌细胞的增殖和迁移［J］. 实用医学杂志， 2024， 40（4）：483-489.

Role of STK4⁃AS1 in regulating malignant biological behavior of esophageal squamous cell carcinoma through the MYG1/Notch signaling pathway

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 25

Related Articles 11

Recommended Articles

Metrics

Comments

[1]	Xiya MA,Hu JI,Zehua ZHU,Bo PAN,Qiang XIE,Xiaobo. YAO. The predictive value of ¹⁸F⁃FDG PET/CT metabolic heterogeneity parameters combined with clinical features for the prognosis of esophageal squamous cell carcinoma before definitive radiochemotherapy [J]. The Journal of Practical Medicine, 2024, 40(7): 966-971.
[2]	DING Shu, HAN Zhuoying, ZHANG Bowei, YU Weiyong, LUO Chao.. Clinical significance of SLC5A12 expression in esophageal squamous cell carcinoma and its effect on malig⁃ nant phenotype of esophageal squamous cell carcinoma [J]. The Journal of Practical Medicine, 2023, 39(6): 730-737.
[3]	WANG Yanxi, KANG Haijun, ZHOU Juan, CHEN Ying, YANG Tao, WANG Min, ZHAO Yueyue, KANG Gangjin.. Effects of lncRNA NALT on H2O2⁃induced injury of human lens epithelial cells by regulating Notch signal⁃ ing pathway [J]. The Journal of Practical Medicine, 2023, 39(2): 217-223.
[4]	Pingping LIN,Fubo LI,Dongjuan WANG,Yan GUO,Yi. DONG. Impacts of circLRP6 on cisplatin resistance to esophageal squamous cell carcinoma by regulating miR⁃125a⁃5p/MCL1 axis [J]. The Journal of Practical Medicine, 2023, 39(17): 2183-2189.
[5]	WANG Jing, YANG Yage, ZHENG Xiaoyong, GUO Changqing. . Efficacy and safety of anlotinib monotherapy as the further ⁃ line treatment for patients with advanced esophageal squamous cell carcinoma [J]. The Journal of Practical Medicine, 2022, 38(7): 893-899.
[6]	HE Keyao, LIU Yiwen, ZHANG Zheyuan, ZHANG Jiahao, DAI Ningtao, YANG Haijun, KONG Jinyu, ZHOU Fuyou.. The clinical significance of high expression of autophagy regulatory protein LC3 induced by Fn in ESCC [J]. The Journal of Practical Medicine, 2022, 38(22): 2787-2794.
[7]	TIAN Qinqin, LI Ang, LI Jiaying, XIE Yuning, WU Hongjiao, ZHANG Xuemei.. Analysis of prognostic biomarkers and pathways in esophageal squamous cell carcinoma [J]. The Journal of Practical Medicine, 2022, 38(1): 73-78.
[8]	CHEN Xiyan, MA Yanjuan, NIU Lidan, YANG Yaqin, YANG Feiyun, SHI Jin⁃he.. Effects of miRNA⁃155 on Notch signaling pathway and autophagy and apoptosis of myocardial cells in oxy⁃ gen⁃glucose deprivation model [J]. The Journal of Practical Medicine, 2021, 37(3): 304-307.
[9]	WANG Zhizhi, WU Xuan⁃zhen, NI Zhen, HE Yujing, DONG Xiaoying, LIU Xiguang, LU Di, CAI Kaican. Role of T lymphocytes in progression of esophageal squamous cell carcinoma [J]. The Journal of Practical Medicine, 2020, 36(24): 3449-3452.
[10]	GU Shudong, MIAO Jiefei, SHEN Hong, ZHANG Shu, MAO Guoxin. Expression of long non⁃coding RNA DLEU1 in esophageal squamous cell carcinoma and its effect on cell proliferation，migration and invasion [J]. The Journal of Practical Medicine, 2020, 36(21): 2911-2915.
[11]	YANG Liang, SHI Ke, LI Minxia, GUO Dan. Ixazomib induces apoptosis of esophageal squamous carcinoma cells through mTOR/p70S6K signaling pathway [J]. The Journal of Practical Medicine, 2020, 36(20): 2780-2785.